Insufficient scRNA-seq data for expression of UGT1A5 at single-cell level.
Insufficient scRNA-seq data for expression of UGT1A5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 49% | 1.87 | 111 / 226 | 6% | 0.47 | 26 / 406 |
bladder | 52% | 2.57 | 11 / 21 | 0% | 0.03 | 2 / 504 |
kidney | 48% | 1.87 | 43 / 89 | 1% | 0.04 | 5 / 901 |
skin | 44% | 1.71 | 796 / 1809 | 0% | 0 | 0 / 472 |
intestine | 31% | 8.61 | 297 / 966 | 1% | 0.01 | 3 / 527 |
stomach | 23% | 0.61 | 83 / 359 | 0% | 0 | 0 / 286 |
esophagus | 22% | 0.76 | 322 / 1445 | 1% | 0.01 | 1 / 183 |
prostate | 13% | 0.37 | 32 / 245 | 0% | 0.00 | 1 / 502 |
thymus | 8% | 0.16 | 53 / 653 | 0% | 0 | 0 / 605 |
lung | 7% | 0.20 | 41 / 578 | 0% | 0.00 | 3 / 1155 |
uterus | 4% | 0.08 | 7 / 170 | 0% | 0.05 | 2 / 459 |
adrenal gland | 4% | 0.07 | 11 / 258 | 0% | 0 | 0 / 230 |
ovary | 4% | 0.11 | 7 / 180 | 0% | 0.00 | 1 / 430 |
adipose | 4% | 0.05 | 49 / 1204 | 0% | 0 | 0 / 0 |
breast | 3% | 0.05 | 13 / 459 | 0% | 0.01 | 2 / 1118 |
pancreas | 2% | 0.06 | 8 / 328 | 1% | 0.01 | 1 / 178 |
spleen | 2% | 0.07 | 6 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 2% | 0.04 | 22 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 2% | 0.03 | 22 / 1335 | 0% | 0 | 0 / 0 |
heart | 2% | 0.04 | 14 / 861 | 0% | 0 | 0 / 0 |
muscle | 2% | 0.05 | 13 / 803 | 0% | 0 | 0 / 0 |
brain | 1% | 0.03 | 34 / 2642 | 0% | 0 | 0 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0052695 | Biological process | cellular glucuronidation |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0015020 | Molecular function | glucuronosyltransferase activity |
GO_0019899 | Molecular function | enzyme binding |
GO_0042803 | Molecular function | protein homodimerization activity |
Gene name | UGT1A5 |
Protein name | UDP-glucuronosyltransferase (EC 2.4.1.17) UDP-glucuronosyltransferase 1A5 (UGT1A5) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-5) (UDPGT 1-5) (UGT1*5) (UGT1-05) (UGT1.5) (UDP-glucuronosyltransferase 1-E) (UGT-1E) (UGT1E) UDP-glucuronosyltransferase 1A5 (EC 2.4.1.17) |
Synonyms | GNT1 hCG_2039726 UGT1 |
Description | FUNCTION: [Isoform 1]: UDP-glucuronosyltransferase (UGT) that catalyzes phase II biotransformation reactions in which lipophilic substrates are conjugated with glucuronic acid to increase the metabolite's water solubility, thereby facilitating excretion into either the urine or bile . Essential for the elimination and detoxification of drugs, xenobiotics and endogenous compounds . Involved in the glucuronidation of the AGTR1 angiotensin receptor antagonist zolarsatan, a drug which can inhibit the effect of angiotensin II . .; FUNCTION: [Isoform 2]: Lacks UGT glucuronidation activity but acts as a negative regulator of isoform 1. . |
Accessions | Q5DSZ9 Q5QTE0 Q5QTE1 F5HPU6 Q5QTE3 Q5QTE4 ENST00000373414.4 [P35504-1] Q5QTE2 P35504 Q5QTD9 Q5QTE5 F5HPU8 |